NEO · Neogenomics Inc · Debt
$17.99
+0.72 (+4.17%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$2.22B
Shares
128.48M
Volume · Oct 28
2.58M
Avg daily vol (3M)
2.18M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current finance lease liabilities | 2026-06-30 | USD 1,704,000 | 10-Q filed 2026-07-28 |
| Current operating lease liabilities | 2026-06-30 | USD 3,722,000 | 10-Q filed 2026-07-28 |
| Noncurrent convertible debt | 2026-06-30 | USD 374,241,000 | 10-Q filed 2026-07-28 |
| Noncurrent finance lease liabilities | 2026-06-30 | USD 4,030,000 | 10-Q filed 2026-07-28 |
| Noncurrent debt carrying amount | 2026-06-30 | USD 374,241,000 | 10-Q filed 2026-07-28 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 64,671,000 | 10-Q filed 2026-07-28 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1077183
CUSIP
64049M209
13F (30d)
57 filings
57 filers
Visit website
Investor relations